[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100645722":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":28,"collaborators":11,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":34,"acronym":35,"eligibilityCriteria":36,"healthyVolunteers":37,"sex":38,"minAge":39,"maxAge":40,"enrollmentInfo":41,"targetDuration":11,"studyType":44,"phases":45,"briefSummary":47,"conditions":48,"keywords":11,"overallStatus":52,"whyStopped":11,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":11},{"fullName":5,"class":6},"Ludwig Boltzmann Institute for Cardiovascular Research","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"perimenopausal women with CVD risk","ACTIVE_COMPARATOR",null,[13,14],"Behavioral: Personal training","Behavioral: App-based physical intervention",{"label":16,"type":10,"description":11,"interventionNames":17},"postmenopausal women with CVD risk",[13,14],[19,24],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"BEHAVIORAL","Personal training","Personal training (strength and endurance, Yoga), nutrition and stress relief advices",[9,16],{"type":20,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"App-based physical intervention","FEM-HEART specific App for life-style modifications including physical exercise, relaxation and nutrition",[9,16],{"type":29,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100645722","female-specific-modifiers-for-healthy-early-action-in-cardiovascular-risk-trajectories-100645722",false,"NCT07703124","Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories","FEM-HEART","Inclusion Criteria:\n\n* women aged \\>35 years in the perimenopausal transition\n* women within 5 years after menopause and and younger than 65 years\n* women with two of the following: (i) established cardiovascular risk factors, such as hypertension, dyslipidemia, overweight, or smoking; (ii) female-specific and hormone-related factors, such as pregnancy-associated complications or early menarche; and (iii) elevated psychosocial stress, assessed by validated questionnaires and physiological proxies.\n\nExclusion Criteria:\n\n* high levels of physical activity\n* hormone replacement therapy\n* major comorbidities such as diabetes, moderate-to-severe kidney or liver disease, malignant tumors, musculoskeletal or neurological conditions limiting mobility, congenital heart defects, prior cardiac events, or a history of thrombosis.",true,"FEMALE","35 Years","65 Years",{"count":42,"type":43},605,"ESTIMATED","INTERVENTIONAL",[46],"NA","Cardiovascular disease is the leading cause of death in women, yet risk is systematically underestimated and preventive interventions are often initiated too late. Women are disproportionately affected by obesity, diabetes, and smoking, but they also derive greater cardioprotective benefit from physical activity, reaching near-maximal protection at approximately half the exercise dose required in men. FEM-HEART targets a critical pre-clinical window by testing whether a personalized app-based intervention and a supervised face-to-face lifestyle program, both integrating tailored exercise, nutrition, and stress reduction, can improve early cardiovascular risk profiles in high-risk women during the peri- and postmenopausal transition.\n\nIn this prospective randomized controlled trial embedded in routine preventive care at SVS Gesundheitszentrum, 605 women will be randomized to a digital arm, a supervised intervention arm, or an untreated control group. The study will evaluate whether digital and supervised delivery formats differ in their ability to modify early cardiovascular trajectories before overt disease onset.\n\nBy targeting this modifiable pre-clinical phase, FEM-HEART shifts cardiovascular prevention from reactive care to proactive, sex-specific risk reduction and lays the foundation for scalable, woman-centered prevention strategies.",[49,50,51],"Perimenopausal Women","Postmenopausal Female Patients","Cardiovascular (CV) Risk","NOT_YET_RECRUITING","2026-07-19",{"date":55,"type":56},"2026-07-21","ACTUAL",{"date":58,"type":43},"2027-06-01",{"date":60,"type":43},"2031-10-31",{"name":5,"class":6}]